There’s No Need To Panic Or Freeze When It Comes To Johnson & Johnson (NYSE: JNJ)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Johnson & Johnson Reports Q4 and Full-Year 2023 Results.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

The company is listed on the NYSE and operates within the Drug Manufacturers – General industry segment. At the end of the last regular session, the stock closed at $158.06 and fluctuated between $158.73 as its day high and $155.60 as its day low. The current market capitalization of Johnson & Johnson is $380.49B. A total of 8.97 million shares were traded on the day, compared to an average of 6.86M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, JNJ has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 25 BUYs and 34 SELLs from insiders. Insiders purchased 193,748 shares during that period but sold 138,919.

In the most recent transaction, Hait William sold 14,698 shares of JNJ for 172.00 per share on Jul 26. After the transaction, the insider now owns 87,747 company shares. In a previous transaction on Jul 25, Fasolo Peter sold 20,000 shares at 170.32 per share. JNJ shares that Exec VP, Chief HR Officer owns now total 102,696.

Among the insiders who sold shares, Wengel Kathryn E disposed of 12,465 shares on Jun 12 at a per-share price of $160.00. This resulted in the EVP, Chief TO and Risk Officer holding 65,934 shares of JNJ after the transaction. In another insider transaction, Swanson James D. sold 1,062 shares at $154.66 per share on Mar 06. Company shares held by the insider now total 9,215.


The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Johnson & Johnson pays an annual dividend of $4.80, resulting in a dividend yield of 3.04%, and it has a price to earnings (P/E) ratio of 28.34. JNJ’s most recent ex-dividend date was 2/16/2024 when it declared a $1.19 quarterly dividend that was paid in cash on 3/5/2024. Previously, the company paid the dividend on 12/5/2023 with an ex-dividend date of 11/20/2023. The JNJ stock dividend was $1.19 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for JNJ in the last 3 months, the mean price target is $175.26 with high estimates of $215.00 and low estimates of $157.00. In terms of 52-week highs and lows, JNJ has a high of $175.97 and a low of $144.95.

As of this writing, JNJ has an earnings estimate of $2.63 per share for the current quarter. EPS was calculated based on a consensus of 15 estimates, with a high estimate of $2.77 per share and a lower estimate of $2.44. The company reported an EPS of $2.66 in the last quarter, which was 5.60% higher than expectations of $2.52.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. JNJ’s latest balance sheet shows that the firm has $31.61B in Cash & Short Term Investments as of fiscal 2021. There were $33.75B in debt and $45.23B in liabilities at the time. Its Book Value Per Share was $29.59, while its Total Shareholder’s Equity was $74.02B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JNJ is Buy with a score of 3.90.

Most Popular

Related Posts